Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Profound Medical Corp (NQ: PROF ) 7.690 UNCHANGED Streaming Delayed Price Updated: 3:59 PM EDT, Oct 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Profound Medical Corp < Previous 1 2 3 Next > iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024 September 20, 2024 Via ACCESSWIRE Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA September 16, 2024 From Profound Medical Corp. Via GlobeNewswire Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference September 04, 2024 From Profound Medical Corp. Via GlobeNewswire Profound Medical: Q4 Earnings Insights March 07, 2024 Via Benzinga PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q2 2024 August 08, 2024 PROF stock results show that Profound Medical beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace Profound Medical Announces Second Quarter 2024 Financial Results August 08, 2024 From Profound Medical Corp. Via GlobeNewswire Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow July 18, 2024 From Profound Medical Corp. Via GlobeNewswire Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday July 16, 2024 Via Benzinga Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases July 11, 2024 From Profound Medical Corp. Via GlobeNewswire Profound Medical Annual General Meeting of Shareholders Voting Results May 15, 2024 From Profound Medical Corp. Via GlobeNewswire Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan May 14, 2024 From Profound Medical Corp. Via GlobeNewswire PROF Stock Earnings: Profound Medical Beats EPS, Misses Revenue for Q1 2024 May 09, 2024 PROF stock results show that Profound Medical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue Guidance May 09, 2024 From Profound Medical Corp. Via GlobeNewswire Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum May 06, 2024 From Profound Medical Corp. Via GlobeNewswire Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow April 22, 2024 From Profound Medical Corp. Via GlobeNewswire Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference April 09, 2024 From Profound Medical Corp. Via GlobeNewswire PROF Stock Earnings: Profound Medical Misses EPS, Beats Revenue for Q4 2023 March 07, 2024 PROF stock results show that Profound Medical missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. Via InvestorPlace Profound Medical Announces Fourth Quarter and Full Year 2023 Financial Results March 07, 2024 From Profound Medical Corp. Via GlobeNewswire Earnings Scheduled For March 7, 2024 March 07, 2024 Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. Via Benzinga Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference March 04, 2024 From Profound Medical Corp. Via GlobeNewswire Profound Medical in Collaboration with Siemens Healthineers to Further Expand Physician and Patient Access to the TULSA Procedure February 27, 2024 From Profound Medical Corp. Via GlobeNewswire Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow February 15, 2024 From Profound Medical Corp. Via GlobeNewswire Profound Medical Announces Non-Brokered Private Placement January 16, 2024 From Profound Medical Corp. Via GlobeNewswire BioMedNewsBreaks – Profound Medical Corp. (TSX: PRN) (NASDAQ: PROF) Announces Pricing of US$20M Public Offering January 04, 2024 Via Investor Brand Network Exposures Product Safety Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues January 03, 2024 From Profound Medical Corp. Via GlobeNewswire Chord Energy, Profound Medical And 3 Stocks To Watch Heading Into Thursday December 28, 2023 With U.S. stock futures trading slightly higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows: Via Benzinga Profound Medical Announces Pricing of US$20 Million Public Offering of Common Shares December 27, 2023 From Profound Medical Corp. Via GlobeNewswire Profound Medical Announces Proposed Public Offering of Common Shares December 27, 2023 From Profound Medical Corp. Via GlobeNewswire Profound Medical to Participate in the Stifel 2023 Healthcare Conference November 08, 2023 From Profound Medical Corp. Via GlobeNewswire Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting November 03, 2023 From Profound Medical Corp. Via GlobeNewswire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.